| Dr Umberto N Orazi, MD | |
|
1189 S Perry St, Suite 230, Castle Rock, CO 80104-1959 | |
| (303) 688-5025 | |
| (303) 688-5029 |
| Full Name | Dr Umberto N Orazi |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 44 Years |
| Location | 1189 S Perry St, Castle Rock, Colorado |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124063417 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 44409 (Colorado) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Jefferson Healthcare Home Health | Port townsend, WA | Home health agency |
| Jefferson Healthcare Home Health | Pt townsend, WA | Hospice |
| Jefferson Healthcare | Port townsend, WA | Hospital |
| Olympic Medical Center | Port angeles, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Jefferson County Public Hospital District No 2 | 4789593708 | 105 |
News Archive
Using a tiny device known as an optical antenna, researchers have created an X-ray sensor that is integrated onto the end of an optical fiber just a few tens of microns in diameter.
Following a priority review, Health Canada has approved Lucentis (ranibizumab) as a treatment for vision loss resulting from retinal vein occlusion (RVO). This makes Lucentis the first approved treatment of its class in Canada for this debilitating condition. Patients will now have access to a treatment that is proven to be effective and has an established safety profile.
People's perceptions of the cost of a drug may affect how much they benefit from the drug, even when they are receiving only a placebo, according to a new study of people with Parkinson's disease published in the January 28, 2015 online issue of Neurology®, the medical journal of the American Academy of Neurology.
The Taiwanese biotechnology industry has started off on the right note with the introduction of several innovative biotechnology-related products and is all set to capitalize on this lead.
"These findings hold great promise for potential treatments for people suffering from macular degeneration, diabetic retinopathy and other retinal diseases," says Michael Young, PhD, an assistant scientist at Schepens Eye Research Institute and the lead author of the study.
› Verified 5 days ago
| Entity Name | Jefferson County Public Hospital District No 2 |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356492953 PECOS PAC ID: 4789593708 Enrollment ID: O20031111000542 |
News Archive
Using a tiny device known as an optical antenna, researchers have created an X-ray sensor that is integrated onto the end of an optical fiber just a few tens of microns in diameter.
Following a priority review, Health Canada has approved Lucentis (ranibizumab) as a treatment for vision loss resulting from retinal vein occlusion (RVO). This makes Lucentis the first approved treatment of its class in Canada for this debilitating condition. Patients will now have access to a treatment that is proven to be effective and has an established safety profile.
People's perceptions of the cost of a drug may affect how much they benefit from the drug, even when they are receiving only a placebo, according to a new study of people with Parkinson's disease published in the January 28, 2015 online issue of Neurology®, the medical journal of the American Academy of Neurology.
The Taiwanese biotechnology industry has started off on the right note with the introduction of several innovative biotechnology-related products and is all set to capitalize on this lead.
"These findings hold great promise for potential treatments for people suffering from macular degeneration, diabetic retinopathy and other retinal diseases," says Michael Young, PhD, an assistant scientist at Schepens Eye Research Institute and the lead author of the study.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Umberto N Orazi, MD 1175 S Perry St Ste 220, Castle Rock, CO 80104-0017 Ph: (303) 688-5025 | Dr Umberto N Orazi, MD 1189 S Perry St, Suite 230, Castle Rock, CO 80104-1959 Ph: (303) 688-5025 |
News Archive
Using a tiny device known as an optical antenna, researchers have created an X-ray sensor that is integrated onto the end of an optical fiber just a few tens of microns in diameter.
Following a priority review, Health Canada has approved Lucentis (ranibizumab) as a treatment for vision loss resulting from retinal vein occlusion (RVO). This makes Lucentis the first approved treatment of its class in Canada for this debilitating condition. Patients will now have access to a treatment that is proven to be effective and has an established safety profile.
People's perceptions of the cost of a drug may affect how much they benefit from the drug, even when they are receiving only a placebo, according to a new study of people with Parkinson's disease published in the January 28, 2015 online issue of Neurology®, the medical journal of the American Academy of Neurology.
The Taiwanese biotechnology industry has started off on the right note with the introduction of several innovative biotechnology-related products and is all set to capitalize on this lead.
"These findings hold great promise for potential treatments for people suffering from macular degeneration, diabetic retinopathy and other retinal diseases," says Michael Young, PhD, an assistant scientist at Schepens Eye Research Institute and the lead author of the study.
› Verified 5 days ago
Christopher Haydek, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 3911 Ambrosia St Ste 201, Castle Rock, CO 80109 Phone: 303-788-8888 Fax: 844-347-5158 | |
Olga Dobranowski, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 6301 Ellingwood Point Pl, Castle Rock, CO 80108 Phone: 630-915-4086 | |
Dr. Anthony Joseph Cedrone, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2352 Meadows Blvd Ste 115, Castle Rock, CO 80109 Phone: 303-744-1065 Fax: 303-733-1699 | |
Christine B Walden, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 4318 Trail Boss Dr, Suite 100, Castle Rock, CO 80104 Phone: 303-338-4545 | |
James Coates, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 5057 Castle Pines Dr S, Castle Rock, CO 80108 Phone: 720-381-0510 | |
Michelle Belle Eason-delhougne, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2352 Meadows Blvd, Ste 300, Castle Rock, CO 80109 Phone: 720-455-3750 Fax: 720-455-3751 |